These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30200844)

  • 1. Preservation of cognitive function following whole brain radiotherapy in patients with brain metastases: Complications, treatments, and the emerging role of memantine.
    Lynch M
    J Oncol Pharm Pract; 2019 Apr; 25(3):657-662. PubMed ID: 30200844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
    Brown PD; Pugh S; Laack NN; Wefel JS; Khuntia D; Meyers C; Choucair A; Fox S; Suh JH; Roberge D; Kavadi V; Bentzen SM; Mehta MP; Watkins-Bruner D;
    Neuro Oncol; 2013 Oct; 15(10):1429-37. PubMed ID: 23956241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for preservation of memory function in patients with brain metastases.
    Dye NB; Gondi V; Mehta MP
    Chin Clin Oncol; 2015 Jun; 4(2):24. PubMed ID: 26112810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001.
    Gondi V; Deshmukh S; Brown PD; Wefel JS; Armstrong TS; Tome WA; Gilbert MR; Konski A; Robinson CG; Bovi JA; Benzinger TLS; Roberge D; Kundapur V; Kaufman I; Shah S; Usuki KY; Baschnagel AM; Mehta MP; Kachnic LA
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):571-580. PubMed ID: 37150264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
    Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
    J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic role of memantine for the prevention of cognitive decline in cancer patients with brain metastasis receiving whole-brain radiotherapy: a narrative review.
    Folloso MC; Torres M; Ciocon SL; Ong JN; Flores JA; Catindig JA
    Dement Neuropsychol; 2022; 16(3):270-275. PubMed ID: 36619840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.
    Slade AN; Stanic S
    Contemp Clin Trials; 2016 Mar; 47():74-7. PubMed ID: 26718093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of cognitive function after brain irradiation.
    Surendran HP; Narmadha MP; Kalavagunta S; Sasidharan A; Dutta D
    J Oncol Pharm Pract; 2022 Jul; 28(5):1182-1188. PubMed ID: 35112915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study.
    Lamba N; Mehanna E; Kearney RB; Catalano PJ; Brown PD; Haas-Kogan DA; Aizer AA
    J Neurooncol; 2020 Jul; 148(3):509-517. PubMed ID: 32468331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory function before and after whole brain radiotherapy in patients with and without brain metastases.
    Welzel G; Fleckenstein K; Schaefer J; Hermann B; Kraus-Tiefenbacher U; Mai SK; Wenz F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1311-8. PubMed ID: 18448270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy.
    Wong P; Leppert IR; Roberge D; Boudam K; Brown PD; Muanza T; Pike GB; Chankowsky J; Mihalcioiu C
    Oncotarget; 2016 Aug; 7(32):50986-50996. PubMed ID: 27248467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
    Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
    Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal-Sparing Whole-Brain Radiotherapy for Lung Cancer.
    Zhao R; Kong W; Shang J; Zhe H; Wang YY
    Clin Lung Cancer; 2017 Mar; 18(2):127-131. PubMed ID: 28340924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiology and radiotherapy of brain metastases.
    Thiagarajan A; Yamada Y
    Clin Exp Metastasis; 2017 Oct; 34(6-7):411-419. PubMed ID: 29139010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Brain metastases: Focal treatment (surgery and radiation therapy) and cognitive consequences].
    Reygagne E; Du Boisgueheneuc F; Berger A
    Bull Cancer; 2017 Apr; 104(4):344-355. PubMed ID: 28161072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Whole Brain Irradiation and Hypo-fractionation Radiotherapy for the Metastases in Non-small Cell Lung Cancer].
    Gu X; Zhao Y; Xu F
    Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):224-9. PubMed ID: 27118651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
    Mahadevan A; Sampson C; LaRosa S; Floyd SR; Wong ET; Uhlmann EJ; Sengupta S; Kasper EM
    Radiat Oncol; 2015 Nov; 10():245. PubMed ID: 26611656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metastases: fractionated whole-brain radiotherapy.
    Wang TJC; Brown PD
    Handb Clin Neurol; 2018; 149():123-127. PubMed ID: 29307349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.